Navigation Links
General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience
Date:11/1/2010

CARLSBAD, Calif., Nov. 1, 2010 /PRNewswire/ -- General Manifolds LLC, a technology company focused on fundamental cognitive algorithms, announced today that the United States Patent and Trademark Office has issued US Patent 7,805,386 covering a computational system and method for simulating functions within the cerebral cortex of the human brain. This ground-breaking technology is relevant to a broad range of applications from artificial intelligence to pharmacology.

The patent, titled "A Method of Generating an Encoded Output Signal Using a Manifold Association Processor Having a Plurality of Pairs of Processing Elements Trained to Store a Plurality of Reciprocal Signal Pairs" describes how physiologically realistic algorithms found in natural intelligence can be used for signal processing, information retrieval, and pattern recognition.

"Neuroscientists have known for some time that sounds, visual images, muscle forces, and the skin surface map topographically onto areas of the brain," said Douglas S. Greer, PhD, President of General Manifolds. "The principles behind the computational manifold automata disclosed in this patent describe how association operators between these maps can be used to create a cognitive symbolic processing system. Moreover, it explains how neurotransmitter molecules can store information efficiently and form the basic substrate of short-term memory."

Traditional approaches in computer vision, speech recognition, and robotics have focused on reducing the images and sounds of the world around us to bits, characters, and other discrete symbols. The invention disclosed describes how a cognitive system based on continuous symbols makes this reduction unnecessary. In addition, the patent discloses a new and more powerful model of neural processing that unifies chemical and electrical computations. Neurotransmitter field theory describes how synapses function as chemical memory cells, forming images like dots of ink on a sheet of paper. Each neuron detects a neurotransmitter image with its dendrites and writes a neurotransmitter image with its axons. Computer simulations of this process may provide important tools in neuropharmacology and medical treatment research.

Since its founding in 2006, General Manifolds has been building an intellectual property portfolio that bridges the gap between biological systems and artificial intelligence.

http://www.gmanif.com


'/>"/>
SOURCE General Manifolds LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Journal of General Physiology explores mysteries of TRP channels in latest Perspectives series
2. American Society for Microbiology to host 109th general meeting in Philadelphia
3. General tumor marker test now offered by GenWay clinical laboratory
4. TWAS 11th General Conference
5. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
6. Modern man found to be generally monogamous, moderately polygamous
7. American Society for Microbiology to host 110th general meeting in San Diego
8. Oil Refineries Announces Delay to Annual & Special General Meeting
9. Mass. General researchers develop functional, transplantable rat liver grafts
10. Major moral decisions use general-purpose brain circuits to manage uncertainty
11. NIAID announces 25 new awards to develop radiation countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)... SAN DIEGO , Feb. 16, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... $5 million Series 1a financing and entered into ... Bank (SVB).  Dermata intends to use the capital ... of making major advancements in the treatment of ...
Breaking Biology Technology: